IBN Initiates Coverage of LIXTE Biotechnology Holdings Inc.
Lixte Biotechnology Holdings, Inc. (LIXT)
NASDAQ:AMEX Investor Relations:
lixte.com/investor_information_02.php
Company Research
Source: GlobeNewswire
AUSTIN, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) -- via IBN – LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a biotech company focused on advancing cancer treatments, has engaged IBN, a multifaceted financial news and publishing company serving private and public entities, to assist with its corporate communications strategy. LIXTE Biotechnology is a clinical-stage pharmaceutical company developing differentiated cancer therapies built around a novel biological target designed to enhance the effectiveness of existing cancer treatments. Rather than introducing standalone drugs, the company is focused on advancing a first-in-class approach intended to improve how chemotherapy and immunotherapy perform in cancers with significant unmet medical need. By integrating its scientific approach into established treatment frameworks, LIXTE aims to expand the reach and impact of current standards of care without requiring wholesale changes to clinical practice. This strategy is reflected in t
Show less
Read more
Impact Snapshot
Event Time:
LIXT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LIXT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LIXT alerts
High impacting Lixte Biotechnology Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
LIXT
News
- LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer Trial [Yahoo! Finance]Yahoo! Finance
- LIXTE and its Collaborators Expand Clear Cell Ovarian Cancer TrialGlobeNewswire
- Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.'s $4.3 Million Registered Direct Offering [Yahoo! Finance]Yahoo! Finance
- Spartan Capital Securities, LLC Serves as Placement Agent in Lixte Biotechnology Holdings, Inc.’s $4.3 Million Registered Direct OfferingGlobeNewswire
- Lixte Biotechnology Holdings, Inc. Announces $4.3 Million Registered Direct Offering Priced at the Market Under Nasdaq RulesGlobeNewswire
LIXT
Sec Filings
- 12/31/25 - Form 8-K
- 12/29/25 - Form 4
- 12/29/25 - Form 4
- LIXT's page on the SEC website